254 related articles for article (PubMed ID: 21577209)
21. Collagen abundance controls melanoma phenotypes through lineage-specific microenvironment sensing.
Miskolczi Z; Smith MP; Rowling EJ; Ferguson J; Barriuso J; Wellbrock C
Oncogene; 2018 Jun; 37(23):3166-3182. PubMed ID: 29545604
[TBL] [Abstract][Full Text] [Related]
22. Targeting invasive properties of melanoma cells.
Arozarena I; Wellbrock C
FEBS J; 2017 Jul; 284(14):2148-2162. PubMed ID: 28196297
[TBL] [Abstract][Full Text] [Related]
23. MT1-MMP dependent repression of the tumor suppressor SPRY4 contributes to MT1-MMP driven melanoma cell motility.
Shaverdashvili K; Zhang K; Osman I; Honda K; Jobava R; Bedogni B
Oncotarget; 2015 Oct; 6(32):33512-22. PubMed ID: 26392417
[TBL] [Abstract][Full Text] [Related]
24. Mitf regulation of Dia1 controls melanoma proliferation and invasiveness.
Carreira S; Goodall J; Denat L; Rodriguez M; Nuciforo P; Hoek KS; Testori A; Larue L; Goding CR
Genes Dev; 2006 Dec; 20(24):3426-39. PubMed ID: 17182868
[TBL] [Abstract][Full Text] [Related]
25. SLFN5 suppresses cancer cell migration and invasion by inhibiting MT1-MMP expression via AKT/GSK-3β/β-catenin pathway.
Wan G; Liu Y; Zhu J; Guo L; Li C; Yang Y; Gu X; Deng LL; Lu C
Cell Signal; 2019 Jul; 59():1-12. PubMed ID: 30844429
[TBL] [Abstract][Full Text] [Related]
26. Microphthalmia-associated transcription factor expression levels in melanoma cells contribute to cell invasion and proliferation.
Vachtenheim J; Ondrušová L
Exp Dermatol; 2015 Jul; 24(7):481-4. PubMed ID: 25866058
[TBL] [Abstract][Full Text] [Related]
27. Silymarin targets β-catenin signaling in blocking migration/invasion of human melanoma cells.
Vaid M; Prasad R; Sun Q; Katiyar SK
PLoS One; 2011; 6(7):e23000. PubMed ID: 21829575
[TBL] [Abstract][Full Text] [Related]
28. WLS inhibits melanoma cell proliferation through the β-catenin signalling pathway and induces spontaneous metastasis.
Yang PT; Anastas JN; Toroni RA; Shinohara MM; Goodson JM; Bosserhoff AK; Chien AJ; Moon RT
EMBO Mol Med; 2012 Dec; 4(12):1294-307. PubMed ID: 23129487
[TBL] [Abstract][Full Text] [Related]
29. The MITF regulatory network in melanoma.
Chauhan JS; Hölzel M; Lambert JP; Buffa FM; Goding CR
Pigment Cell Melanoma Res; 2022 Sep; 35(5):517-533. PubMed ID: 35771179
[TBL] [Abstract][Full Text] [Related]
30. Alantolactone Inhibits Melanoma Cell Culture Viability and Migration and Promotes Apoptosis by Inhibiting Wnt/β-Catenin Signaling.
Zhang L; Chen J; Chen Y; Zou D; Pu Y; Wei M; Huang Y; Li Y; Huang Q; Chen J
Anticancer Agents Med Chem; 2023; 23(1):94-104. PubMed ID: 35598249
[TBL] [Abstract][Full Text] [Related]
31. Inducibly decreased MITF levels do not affect proliferation and phenotype switching but reduce differentiation of melanoma cells.
Vlčková K; Vachtenheim J; Réda J; Horák P; Ondrušová L
J Cell Mol Med; 2018 Apr; 22(4):2240-2251. PubMed ID: 29369499
[TBL] [Abstract][Full Text] [Related]
32. Wnt-signaling enhances neural crest migration of melanoma cells and induces an invasive phenotype.
Sinnberg T; Levesque MP; Krochmann J; Cheng PF; Ikenberg K; Meraz-Torres F; Niessner H; Garbe C; Busch C
Mol Cancer; 2018 Feb; 17(1):59. PubMed ID: 29454361
[TBL] [Abstract][Full Text] [Related]
33. miR-137 inhibits the invasion of melanoma cells through downregulation of multiple oncogenic target genes.
Luo C; Tetteh PW; Merz PR; Dickes E; Abukiwan A; Hotz-Wagenblatt A; Holland-Cunz S; Sinnberg T; Schittek B; Schadendorf D; Diederichs S; Eichmüller SB
J Invest Dermatol; 2013 Mar; 133(3):768-775. PubMed ID: 23151846
[TBL] [Abstract][Full Text] [Related]
34. The role of Wnt/β-catenin signaling pathway in melanoma epithelial-to-mesenchymal-like switching: evidences from patients-derived cell lines.
Kovacs D; Migliano E; Muscardin L; Silipo V; Catricalà C; Picardo M; Bellei B
Oncotarget; 2016 Jul; 7(28):43295-43314. PubMed ID: 27175588
[TBL] [Abstract][Full Text] [Related]
35. MicroRNA-329 upregulation impairs the HMGB2/β-catenin pathway and regulates cell biological behaviors in melanoma.
Mo Y; Fang RH; Wu J; Si Y; Jia SQ; Li Q; Bai JZ; She XN; Wang JQ
J Cell Physiol; 2019 Dec; 234(12):23518-23527. PubMed ID: 31219186
[TBL] [Abstract][Full Text] [Related]
36. The roles of microphthalmia-associated transcription factor and pigmentation in melanoma.
Hsiao JJ; Fisher DE
Arch Biochem Biophys; 2014 Dec; 563():28-34. PubMed ID: 25111671
[TBL] [Abstract][Full Text] [Related]
37. Differential LEF1 and TCF4 expression is involved in melanoma cell phenotype switching.
Eichhoff OM; Weeraratna A; Zipser MC; Denat L; Widmer DS; Xu M; Kriegl L; Kirchner T; Larue L; Dummer R; Hoek KS
Pigment Cell Melanoma Res; 2011 Aug; 24(4):631-42. PubMed ID: 21599871
[TBL] [Abstract][Full Text] [Related]
38. 3D-microenvironments initiate TCF4 expression rescuing nuclear β-catenin activity in MCF-7 breast cancer cells.
Sergio S; Coluccia AML; Lemma ED; Spagnolo B; Vergara D; Maffia M; De Vittorio M; Pisanello F
Acta Biomater; 2020 Feb; 103():153-164. PubMed ID: 31843716
[TBL] [Abstract][Full Text] [Related]
39. Regulation of MT1-MMP activity by β-catenin in MDCK non-cancer and HT1080 cancer cells.
Liu P; Yang J; Pei J; Pei D; Wilson MJ
J Cell Physiol; 2010 Nov; 225(3):810-21. PubMed ID: 20589835
[TBL] [Abstract][Full Text] [Related]
40. Tspan8-β-catenin positive feedback loop promotes melanoma invasion.
El Kharbili M; Agaësse G; Barbollat-Boutrand L; Pommier RM; de la Fouchardière A; Larue L; Caramel J; Puisieux A; Berthier-Vergnes O; Masse I
Oncogene; 2019 May; 38(20):3781-3793. PubMed ID: 30679790
[TBL] [Abstract][Full Text] [Related]
[Previous] [Next] [New Search]
